advertisement
11.3.3 Apraclonidine, brimonidine (6)
Showing records 1 to 6
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine17155 Brimonidine in the treatment of glaucoma and ocular hypertension
Cantor LB
Therapeutics and Clinical Risk Management 2006; 2: 337-346
17041 Interest of α2-adrenergic agonists and antagonists in clinical practice: Background, facts and perspectives
Crassous P-A; Denis C; Paris H; Senard JM
Current Topics in Medicinal Chemistry 2007; 7: 187-194
16813 Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy
Danylkova NO; Alcala SR; Pomeranz HD; McLoon LK
Experimental Eye Research 2007; 84: 293-301
17042 Agonists and antagonists targeting the different α2-adrenoceptor subtypes
Gentili F; Pigini M; Piergentili A; Giannella M
Current Topics in Medicinal Chemistry 2007; 7: 163-186
16759 Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma
Fung AT; Reid SE; Jones MP; Healey PR; McCluskey PJ; Craig JC
British Journal of Ophthalmology 2007; 91: 62-68
16791 The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma
Hollo G; Chiselita D; Petkova N; Cvenkel B; Liehneova I; Izgi B; Berta A; Szaflik J; Turacli E; Stewart WC
European Journal of Ophthalmology 2006; 16: 816-823
